An Efficacy and Safety Study of Escitalopram Long-Term Treatment in Major Depressive Disorder With Associated Anxiety Symptoms

NCT01814098 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

318

Enrollment

INDUSTRY

Sponsor class

Conditions

Depressive Disorder, Major

Interventions

DRUG: Escitalopram

Sponsor

Xian-Janssen Pharmaceutical Ltd.